Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Antengene Announces IND Approval in China for the Phase I Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma 2022-03-10 08:52
Transcenta Presented Safety / Tolerability and Preliminary Anti-tumor Activity Data in Gastric and Pancreatic Cancers of TST001 Monotherapy from China Phase I Clinical Trial at the 2022 International Gastric Cancer Congress 2022-03-10 08:30
Bridge Biotherapeutics to Present Preclinical Data of BBT-207 at the AACR 2022 Annual Meeting 2022-03-10 07:00
Insilico Medicine enters research collaboration with the University of Zurich to apply Insilico's generative Artificial Intelligence platform for the discovery of potential therapeutics for Cystinosis 2022-03-10 00:57
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific 2022-03-09 21:57
NCCN Expands Resources for Treating Rare Cancer Types 2022-03-09 21:56
Antengene Announces Five Upcoming Presentations at the 2022 American Association for Cancer Research Annual Meeting 2022-03-09 20:00
Antengene Announces XPOVIO® Approved by the TGA in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Triple Class-Refractory Multiple Myeloma 2022-03-09 19:08
Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022 2022-03-09 07:47
ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer 2022-03-09 06:58
FIRST SURGERIES COMPLETED WITH PATIENT-SPECIFIC 3D PRINTED IMPLANTS PRODUCED AT THE LIMACORPORATE PROMADE POINT OF CARE CENTER AT HOSPITAL FOR SPECIAL SURGERY 2022-03-09 06:16
Terran Biosciences and University of Maryland, Baltimore announce exclusive licensing deal for a portfolio of patents and data supporting novel innovation in the psychedelic therapeutic space 2022-03-09 06:10
Gracell Biotechnologies Announces Details of Poster Presentation at AACR Annual Meeting 2022 2022-03-09 05:30
Artilux Demonstrates New Breakthrough for Multi Spectral Optical Sensing 2022-03-08 20:56
Femtech after COVID-19: How to Break the Bias and Meet Women's Untapped Healthcare Needs in 2022 2022-03-08 17:02
SNIPR BIOME announces opening of new BSL2/GMO2-classified laboratory in Copenhagen, Denmark 2022-03-08 15:31
WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies 2022-03-08 08:00
Bridge Biotherapeutics Enters into an Option-to-License Agreement with CellionBioMed to Develop BBT-301 for the Treatment of Multiple Fibrotic Diseases 2022-03-08 08:00
Singleron Acquires Proteona 2022-03-07 23:00
Alterity Therapeutics to Present at the 34th Annual Roth Conference 2022-03-07 20:59
1 188 189 190 191 192 452